Shares of ENZC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard
Vanguard
The Vanguard Group is an American registered investment advisor based in Malvern, Pennsylvania with over $5.3 trillion in assets under management. It is the largest provider of mutual funds and the second-largest provider of exchange-traded funds in the world after BlackR…
Brokerage firm
A brokerage firm, or simply brokerage, is a financial institution that facilitates the buying and selling of financial securities between a buyer and a seller. Brokerage firms serve a clientele of investors who trade public stocks and other securities, usually through the firm's agent stockbrokers. A traditional, or "full service," brokerage firm usually undertakes more than simply carrying out a stock or bond tr…
TD Ameritrade
TD Ameritrade is a broker that offers an electronic trading platform for the trade of financial assets including common stocks, preferred stocks, futures contracts, exchange-traded funds, options, cryptocurrency, mutual funds, and fixed income investments. It also provides margin lending, an…
Fidelity Investments
Fidelity Investments Inc., commonly referred to as Fidelity, earlier as Fidelity Management & Research or FMR, is an American multinational financial services corporation based in Boston, Massachusetts.
Where can I buy shares of enzc?
Shares of ENZC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is enzolytics (Enz) a good stock to buy?
Enzolytics Incholds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
What is the enzc stock price prediction for 2027-02-24?
Based on our forecasts, a long-term increase is expected, the "ENZC" stock price prognosis for 2027-02-24 is 2.501 USD. With a 5-year investment, the revenue is expected to be around +2924.62%. Your current $100 investment may be up to $3024.62 in 2027.
Will enzolytics (enzc) outperform or underperform the S&P 500?
MarketBeat's community ratings are surveys of what our community members think about Enzolytics and other stocks. Vote “Outperform” if you believe ENZC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ENZC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Can I buy ENZC with fidelity?
Yes, please! Use the ticker search box.
Is ENZC a good investment?
If you are looking for stocks with good return, Enzolytics Inc can be a profitable investment option. Enzolytics Inc quote is equal to 0.0592 USD at 2022-06-03. Based on our forecasts, a long-term increase is expected, the "ENZC" stock price prognosis for 2027-05-26 is 0.997 USD.
Who owns ENZC stock?
Largest shareholders include MAI Capital Management, Captrust Financial Advisors, NorthCrest Asset Manangement, LLC, IFP Advisors, Inc, and Winch Advisory Services, LLC.
Is ENZC an OTC stock?
ENZC Stock Price | Enzolytics Inc. Stock Quote (U.S.: OTC) | MarketWatch.
Can you buy ENZC on Etrade?
Shares of ENZC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many shares does ENZC have?
Share StatisticsAvg Vol (3 month) 38.66MShares Outstanding 52.44BImplied Shares Outstanding 6N/AFloat 8N/A% Held by Insiders 10.00%7 more rows
Is ENZC on Nasdaq?
Enzolytics Inc (ENZC) Stock Price, Quote, News & History | Nasdaq.
What kind of stock is ENZC?
(ENZC) ("the Company"), a drug development company committed to commercializing its proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases.
Is ENZC Pink Current?
Enzolytics Inc (OTC Pink - Current Information:ENZC) The company's all-human monoclonal antibodies target and neutralize human immunodeficiency virus, and are being employed to produce anti-SARS-CoV-2 monoclonal antibodies for treating COVID-19.
How has Enzolytics' stock performed in 2022?
Enzolytics' stock was trading at $0.0690 at the beginning of 2022. Since then, ENZC shares have increased by 4.3% and is now trading at $0.0720. V...
Who are Enzolytics' key executives?
Enzolytics' management team includes the following people: Mr. Charles S. Cotropia , CEO, Pres & Director Dr. Gaurav Chandra M.D. , COO & Direct...
Who are some of Enzolytics' key competitors?
Some companies that are related to Enzolytics include 3SBio (TRSBF) , 45525 (CUR.TO) (CUR) , Abattis Bioceuticals (ATTBF) , Abcam (ABCZF) , Ab...
What is Enzolytics' stock symbol?
Enzolytics trades on the OTCMKTS under the ticker symbol "ENZC."
How do I buy shares of Enzolytics?
Shares of ENZC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Enzolytics' stock price today?
One share of ENZC stock can currently be purchased for approximately $0.07.
How many employees does Enzolytics have?
Enzolytics employs 2 workers across the globe.
What is Enzolytics' official website?
The official website for Enzolytics is enzolytics.com .
How can I contact Enzolytics?
The company can be reached via phone at (972) 292-9414 .
"Should I invest in Enzolytics stock?" "Should I trade "ENZC" stock today?"
According to our live Forecast System, Enzolytics Inc stock is an awesome long-term (1-year) inves...
What is the Enzolytics stock price / share price today?
The Enzolytics stock price is 0.0676 USD today.
Will Enzolytics stock price grow / rise / go up?
Yes. The ENZC stock price can go up from 0.0676 USD to 7.427 USD in...
Is it profitable to invest in Enzolytics stock?
Yes. The long-term earning potential is + 10886.58 % in one year.
Will ENZC stock price fall / drop?
No. See above .
What will Enzolytics stock price be worth in five years (2027)?
The ENZC ("ENZC" ) future stock price will be 18.866 USD .
Will ENZC stock price crash?
According to our analysis, this will not happen.
Will Enzolytics stock price hit 1 USD price in a year?
Yes, within a year. See above .
Will Enzolytics stock price hit 5 USD price in a year?
Yes, within a year. See above .
How much are Enzolytics shares worth in 2020?
If you had bought $1,000 worth of Enzolytics shares at the start of February 2020, those shares would have been worth $600.00 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $259,400.00.
When did Enzolytics split?
Enzolytics's shares were split on a 1:500 basis on 6 February 2013. So if you had owned 500 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Enzolytics shares – just the quantity.
What was the last close of Enzolytics?
Since the stock market crash that started in February 2020, Enzolytics's share price has had significant positive movement. Its last market close was $0.1297, which is 99.77% up on its pre-crash value of $0.0003 and 129,600.00% up on the lowest point reached during the March 2020 crash when the shares fell as low as $0.0001.
What is beta in Enzolytics?
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Enzolytics's is -2.2524. This would suggest that Enzolytics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Enzolytics has bucked the trend.
Are investors shorting Enzolytics?
Enzolytics saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 3,876,400 shares, an increase of 59.2% from the December 31st total of 2,434,400 shares.
Who are some of Enzolytics' key competitors?
Some companies that are related to Enzolytics include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abcam (ABCZF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), ALK-Abello A/S (AKBLF), Almirall (LBTSF), Amarantus BioScience (AMBS) and Amplia Therapeutics (ATX). View all of ENZC's competitors..
How do I buy shares of Enzolytics?
Shares of ENZC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is Enzolytics' stock price today?
One share of ENZC stock can currently be purchased for approximately $0.08.
Enzolytics Reports Its Engagement of Scendea USA, Inc., a Leading International Product Development and Regulatory Consulting Group, To Guide the Progress Toward Clinical Trials and Market Approval for Its Itv-1 Anti-HIV Therapeutic
COLLEGE STATION, TX / ACCESSWIRE / December 29, 2021 / Enzolytics, Inc.com), a leading international product development and regulatory consulting group, to advance its anti-HIV therapeutic ITV-1 to production, clinical trials and market approval under both the European Medicines Act (EMA) and the U.
Enzolytics Announces Progress As It Recognizes World AIDS Day
COLLEGE STATION, TX / ACCESSWIRE / December 2, 2021 / Enzolytics wishes to recognize and acknowledge World AIDS Day - a day to call attention to the continued need for a more effective treatment for HIV, including successful treatments for the growing number of individuals living longer with HIV.7 million people in the world have HIV, yet the only treatment available is antiretrovirals (ARVs), which do not cure, are tremendously expensive, are only available to 46% of those infected and have sig.
ENZC Stock News
This Texas-based biotech company is concerned with the development of therapeutics which could treat a variety of diseases. Using its patented technology and proprietary methodology, ENZC has had great results in identifying sites on viruses to neutralize and treat them while protecting against mutations.
ENZC Stock Forecast 2022
Revolutionizing the approach to the treatment and identification of diseases, ENZC is already gearing up to compete against Big Pharma companies. The company is working to produce antibodies for the treatment of Omicron, Small-Pox, Ebola Virus, Tetanus, and Rabies and has applied to the National Institute of Health for funding.
Technical Analysis
ENZC stock price is currently $.1365 after seeing notable growth so far this year. With a support at .0836 and .1114, ENZC stock has a new resistance near .1571. If the stock is able to maintain this momentum and break through its resistance, it could return to ENZC stock price in October at $.19 or more.
ENZC Stock Forecast 2022
At the moment, ENZC stock has a long list of catalysts ranging from plans to uplist to their ground-breaking patents and technology partnerships. The company’s focus on the treatment of infectious diseases has made it particularly attractive to investors watching the Omicron Variant’s surge.
Analyst Opinions
The Equity Summary Score is an accuracy-weighted sentiment derived from the ratings of independent research providers on Fidelity.com. It uses the past relative accuracy of the providers in determining the emphasis placed on any individual opinion. Learn More....
Research Reports
This generated report* compiles independent, third-party information highlighting key fundamental and technical data, analyst opinions, stock price movement, earnings data, and industry comparisons. Available only to Fidelity customers.
Compare
Sorry - there is currently no Compare information available for this stock.
